← All Conditions ← Cancer Overview

Cancer — Female Reproductive System

★ CMTO Exam Focus

Female reproductive system cancers include malignancies of the breasts, ovaries, uterus (endometrium), and cervix. Breast cancer is the second leading cause of cancer death in women, while ovarian cancer is known as the "silent killer" due to vague early symptoms that mimic GI or perimenopause complaints. BRCA1/2 gene mutations significantly increase risk for both breast and ovarian cancers. MTs must understand bone metastasis risk, lymphedema from axillary node dissection, and the psychosocial impact of disfiguring treatments.

Pathophysiology

  • Breast cancer: Typically presents as a painless lump or skin texture changes. Commonly metastasizes to spine, pelvis, and long bones
  • Cervical cancer: Strongly linked to HPV. Most curable if detected early via Pap tests
  • Uterine (endometrial) cancer: Most common pelvic cancer in females. Triggered by excessive estrogen exposure
  • Ovarian cancer: "Silent killer" — symptoms are vague and nonspecific until peritoneal metastasis
  • Tamoxifen paradox: Blocks estrogen receptors in breast tissue but acts as a weak estrogen in the uterus, potentially increasing endometrial cancer risk
  • Hormonal risk factors include early menarche, late menopause, nulliparity, first child after age 30, HRT, and obesity (fat cells produce estrogen)

Signs and Symptoms

Hallmark Indicators

  • Breast: Painless lump. "orange peel" skin (peau d'orange). Inverted nipples. Redness or scaling
  • Cervical: Often asymptomatic early. Abnormal bleeding or discharge
  • Uterine: Postmenopausal bleeding (most dependable early sign). Spotting between periods
  • Ovarian: Persistent bloating or abdominal swelling (ascites). Pelvic heaviness. Bowel/bladder habit changes
  • General: Unexplained weight loss, persistent fatigue, drenching night sweats

Red Flags and Rule-Outs

  • Postmenopausal bleeding: Most dependable early sign of uterine cancer — immediate referral
  • Painless breast lump with skin changes: Refer for mammography/biopsy
  • Persistent bloating + pelvic heaviness: Often mistaken for GI distress or perimenopause. Ovarian cancer must be ruled out
  • Any unexplained lump >5 cm or deep bone pain worse at night: Immediate medical referral
  • Axillary lymph node fixed and nontender: Suggests breast cancer metastasis to sentinel node

MT Considerations

  • Goal: Palliative support to alleviate pain, anxiety, nausea, fatigue, and depression
  • Bone fragility: Breast cancer commonly metastasizes to spine, pelvis, and long bones. Extreme caution with pressure
  • Lymphedema: Axillary node dissection or radiation creates lifelong upper extremity lymphedema risk. Conservative massage or specialized MLD required (see mastectomy)
  • Psychosocial impact: Disfiguring surgeries (mastectomy, hysterectomy) often cause altered body image, anxiety, and depression. Nurturing touch is essential
  • Positioning: Clients with ascites may not tolerate prone or supine. Side-lying or semi-reclined preferred
  • Treatment side effects: See chemotherapy and radiation-therapy

CMTO Exam Relevance

  • Postmenopausal bleeding is the most dependable early sign of uterine cancer
  • Ovarian cancer symptoms are often mistaken for GI distress or perimenopause
  • BRCA1/2 mutations increase risk for both breast and ovarian cancers
  • Sentinel node biopsy status determines extent of surgical resection
  • Breast cancer commonly metastasizes to bone — always assess for deep bone pain

Key Takeaways

  • Female reproductive cancers include breast, cervical, uterine, and ovarian malignancies with distinct presentations
  • Postmenopausal bleeding is the most reliable early sign of uterine cancer. Ovarian cancer is a "silent killer"
  • BRCA1/2 mutations significantly increase risk for both breast and ovarian cancers
  • Breast cancer commonly metastasizes to spine, pelvis, and long bones, creating high fracture risk
  • Lymphedema is a lifelong risk following axillary lymph node surgery or radiation

Sources

  • Rattray, F., & Ludwig, L. (2000). Clinical massage therapy: Understanding, assessing and treating over 70 conditions. Talus Incorporated.
  • Werner, R. (2016). A massage therapist's guide to pathology (6th ed.). Books of Discovery.
  • Norris, T. L. (2019). Porth's essentials of pathophysiology (5th ed.). Wolters Kluwer.